Brandy Rutledge

2.9k total citations
23 papers, 1.9k citations indexed

About

Brandy Rutledge is a scholar working on Endocrinology, Diabetes and Metabolism, Urology and Infectious Diseases. According to data from OpenAlex, Brandy Rutledge has authored 23 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Urology and 5 papers in Infectious Diseases. Recurrent topics in Brandy Rutledge's work include Urinary Bladder and Prostate Research (6 papers), Vitamin D Research Studies (5 papers) and Diabetes Management and Research (5 papers). Brandy Rutledge is often cited by papers focused on Urinary Bladder and Prostate Research (6 papers), Vitamin D Research Studies (5 papers) and Diabetes Management and Research (5 papers). Brandy Rutledge collaborates with scholars based in United States, Canada and Belgium. Brandy Rutledge's co-authors include John M. Lachin, Bernard Zinman, Patricia A. Cleary, David M. Nathan, Saul Genuth, Craig M. Wilson, Bill G. Kapogiannis, Hunter Wessells, Sybil Hosek and Michelle Lally and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetes.

In The Last Decade

Brandy Rutledge

23 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brandy Rutledge United States	19	693	604	497	212	194	23	1.9k
Neri Alejandro Álvarez‐Villalobos Mexico	14	331 0.5×	63 0.1×	201 0.4×	112 0.5×	77 0.4×	65	1.1k
Luigi Napolitano Italy	21	111 0.2×	115 0.2×	425 0.9×	160 0.8×	156 0.8×	103	1.5k
Anju Seth India	19	277 0.4×	148 0.2×	156 0.3×	61 0.3×	120 0.6×	114	1.3k
Rajesh Rajput India	21	798 1.2×	90 0.1×	245 0.5×	73 0.3×	24 0.1×	132	1.4k
Luther B. Travis United States	25	802 1.2×	43 0.1×	269 0.5×	50 0.2×	32 0.2×	85	2.1k
Norman A. Beischer Australia	34	339 0.5×	86 0.1×	179 0.4×	59 0.3×	51 0.3×	170	3.4k
Andrea V. Margulis United States	19	123 0.2×	152 0.3×	280 0.6×	46 0.2×	97 0.5×	41	1.5k
S. Bouée France	23	149 0.2×	115 0.2×	641 1.3×	60 0.3×	52 0.3×	96	1.7k
Laura Edwards United States	16	214 0.3×	32 0.1×	270 0.5×	86 0.4×	37 0.2×	38	1.3k
Federica Carli Italy	21	234 0.3×	1.1k 1.8×	644 1.3×	40 0.2×	101 0.5×	42	2.2k

Countries citing papers authored by Brandy Rutledge

Since Specialization

Citations

This map shows the geographic impact of Brandy Rutledge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandy Rutledge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandy Rutledge more than expected).

Fields of papers citing papers by Brandy Rutledge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brandy Rutledge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandy Rutledge. The network helps show where Brandy Rutledge may publish in the future.

Co-authorship network of co-authors of Brandy Rutledge

This figure shows the co-authorship network connecting the top 25 collaborators of Brandy Rutledge. A scholar is included among the top collaborators of Brandy Rutledge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brandy Rutledge. Brandy Rutledge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Havens, Peter L., Marta D. Van Loan, G Schuster, et al.. (2017). Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults with HIV Infection Being Treated with Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial. Clinical Infectious Diseases. 1 indexed citations

Havens, Peter L., Charles B. Stephensen, Marta D. Van Loan, et al.. (2016). Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis. Clinical Infectious Diseases. 64(3). 317–325. 39 indexed citations

Hosek, Sybil, Bret J. Rudy, Raphael J. Landovitz, et al.. (2016). An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM. JAIDS Journal of Acquired Immune Deficiency Syndromes. 74(1). 21–29. 222 indexed citations

Rutledge, Brandy, et al.. (2014). Contribution of Infrastructure to Oil and Gas Production and Processing Carbon Footprint. 6 indexed citations

Hosek, Sybil, George K. Siberry, Margo Bell, et al.. (2012). The Acceptability and Feasibility of an HIV Preexposure Prophylaxis (PrEP) Trial With Young Men Who Have Sex With Men. JAIDS Journal of Acquired Immune Deficiency Syndromes. 62(4). 447–456. 145 indexed citations

Havens, Peter L., Kathleen Mulligan, Rohan Hazra, et al.. (2012). Serum 25-Hydroxyvitamin D Response to Vitamin D₃Supplementation 50,000 IU Monthly in Youth with HIV-1 Infection. The Journal of Clinical Endocrinology & Metabolism. 97(11). 4004–4013. 38 indexed citations

Havens, Peter L., Charles B. Stephensen, Rohan Hazra, et al.. (2012). Vitamin D3 Decreases Parathyroid Hormone in HIV-Infected Youth Being Treated With Tenofovir: A Randomized, Placebo-Controlled Trial. Clinical Infectious Diseases. 54(7). 1013–1025. 57 indexed citations

Wessells, Hunter, David F. Penson, Patricia A. Cleary, et al.. (2011). Effect of Intensive Glycemic Therapy on Erectile Function in Men With Type 1 Diabetes. The Journal of Urology. 185(5). 1828–1834. 68 indexed citations

Younes, Naji, Patricia A. Cleary, Michael W. Steffes, et al.. (2010). Comparison of Urinary Albumin-Creatinine Ratio and Albumin Excretion Rate in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study. Clinical Journal of the American Society of Nephrology. 5(7). 1235–1242. 49 indexed citations

10.

Molitch, Mark E., Michael W. Steffes, Wanjie Sun, et al.. (2010). Development and Progression of Renal Insufficiency With and Without Albuminuria in Adults With Type 1 Diabetes in the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study. Diabetes Care. 33(7). 1536–1543. 200 indexed citations

11.

Sarma, Aruna V., Alka M. Kanaya, Leroy M. Nyberg, et al.. (2009). Urinary Incontinence Among Women With Type 1 Diabetes—How Common is it?. The Journal of Urology. 181(3). 1224–1230. 31 indexed citations

12.

Sarma, Aruna V., Alka M. Kanaya, Leroy M. Nyberg, et al.. (2009). Risk Factors for Urinary Incontinence Among Women With Type 1 Diabetes: Findings From the Epidemiology of Diabetes Interventions and Complications Study. Urology. 73(6). 1203–1209. 34 indexed citations

13.

Enzlin, Paul, Raymond C. Rosen, Markus Wiegel, et al.. (2009). Sexual Dysfunction in Women With Type 1 Diabetes. Diabetes Care. 32(5). 780–785. 139 indexed citations

14.

Czaja, Christopher A., Brandy Rutledge, Patricia A. Cleary, et al.. (2009). Urinary Tract Infections in Women With Type 1 Diabetes Mellitus: Survey of Female Participants in the Epidemiology of Diabetes Interventions and Complications Study Cohort. The Journal of Urology. 181(3). 1129–1135. 27 indexed citations

15.

Eeden, Stephen K. Van Den, Aruna V. Sarma, Brandy Rutledge, et al.. (2009). Effect of Intensive Glycemic Control and Diabetes Complications on Lower Urinary Tract Symptoms in Men With Type 1 Diabetes. Diabetes Care. 32(4). 664–670. 55 indexed citations

16.

Penson, David F., Hunter Wessells, Patricia A. Cleary, & Brandy Rutledge. (2009). Sexual Dysfunction and Symptom Impact in Men with Long-Standing Type 1 Diabetes in the DCCT/EDIC Cohort. The Journal of Sexual Medicine. 6(7). 1969–1978. 33 indexed citations

17.

Lachin, John M., Saul Genuth, David M. Nathan, Bernard Zinman, & Brandy Rutledge. (2008). Effect of Glycemic Exposure on the Risk of Microvascular Complications in the Diabetes Control and Complications Trial—Revisited. Diabetes. 57(4). 995–1001. 381 indexed citations

18.

Nathan, David M., Saul Genuth, Brandy Rutledge, & John M. Lachin. (2008). Response to Comment on: Lachin et al. (2007) The Hemoglobin Glycation Index Is Not an Independent Predictor of the Risk of Microvascular Complications in the Diabetes Control and Complications Trial: Diabetes 56:1913–1921, 2007. Diabetes. 57(2). e5–e5. 2 indexed citations

19.

Paterson, Andrew D., Brandy Rutledge, Patricia A. Cleary, John M. Lachin, & Richard S. Crow. (2007). The Effect of Intensive Diabetes Treatment on Resting Heart Rate in Type 1 Diabetes. Diabetes Care. 30(8). 2107–2112. 59 indexed citations

20.

Lachin, John M., Saul Genuth, David M. Nathan, & Brandy Rutledge. (2007). The Hemoglobin Glycation Index Is Not an Independent Predictor of the Risk of Microvascular Complications in the Diabetes Control and Complications Trial. Diabetes. 56(7). 1913–1921. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact